CIK: 0001019231 · Show all filings
Period: Q2 2015 (← Previous) (Next →)
Filing Date: Aug 13, 2015
Total Value ($000): $279,876 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ZIOPHARM ONCOLOGY INC | 12,062,803 | $144,754 | 51.7% | $10.80 | — | COM | 98973P101 |
| — | INTREXON CORPORATION | 2,100,085 | $102,484 | 36.6% | $45.37 | — | COM | 46122T102 |
| — | WILLIAMS PARTNERS LP | 172,732 | $8,365 | 3.0% | $49.22 | — | LP - PUBLIC EQUITY | 96949L105 |
| — | BIO-PATH HOLDINGS INC | 3,830,882 | $4,406 | 1.6% | $2.63 | — | COM | 09057N102 |
| VOO | VANGUARD 500 INDEX FUND | 16,421 | $3,101 | 1.1% | $180.81 | — | ETFS | 922908363 |
| VEA | VANGUARD FTSE DEV MKTS | 65,204 | $2,585 | 0.9% | $39.75 | — | ETFS | 921943858 |
| VWO | VANGUARD MSCI EMERGING MKTS | 60,541 | $2,475 | 0.9% | $40.58 | — | ETFS | 922042858 |
| VOE | VANGUARD MID-CAP VALUE ETF | 26,234 | $2,376 | 0.8% | $85.13 | — | ETFS | 922908512 |
| — | GENERAL MOLY INC | 2,922,831 | $2,069 | 0.7% | $1.15 | — | COM | 370373102 |
| VDE | VANGUARD ENERGY ETF | 17,039 | $1,822 | 0.7% | $127.71 | — | ETFS | 92204A306 |
| GLD | SPDR GOLD TRUST | 15,361 | $1,726 | 0.6% | $122.11 | — | ETFS | 78463V107 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $1,648 | 0.6% | $25.31 | +63.0% | COM | 882508104 |
| VNQ | VANGUARD REIT ETF | 18,431 | $1,377 | 0.5% | $72.18 | — | ETFS | 922908553 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $287 | 0.1% | $7.34 | 0.0% | COM | 528872302 |
| — | MOBILEYE | 3,900 | $207 | 0.1% | $53.08 | — | COM | N51488117 |
| IVZ | INVESCO LTD | 5,000 | $187 | 0.1% | $24.92 | 0.0% | COM | G491BT108 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $4 | 0.0% | $20.00 | +18.6% | COM | 736508847 |
| EFX | EQUIFAX INC. | 29 | $3 | 0.0% | $62.16 | +41.8% | COM | 294429105 |